tenk.fyi

Celldex Therapeutics, Inc.

CLDXNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$1.5M

78.0% YoY

Net Income

-$258.8M

63.9% YoY

EPS

$-3.90

59.2% YoY

Cash

$28.9M

1.8% YoY

FY 2025 · As of 2025-12-31